Player FM 앱으로 오프라인으로 전환하세요!
Target enrichment for NGS: why, how and what's next?
Manage episode 305554977 series 2902208
In this episode, supported by Roche, we explore a vital aspect of many next-generation sequencing studies: target enrichment. Here, regions of interest are selectively amplified before sequencing takes place. More specifically we examine some of the new technologies improving this key step and their impact on oncology research.
My guest for this episode is Brian Godwin, Director of Reagent and Assay Development at Roche sequencing. Brian reveals the myriad of ways that poor target enrichment can impact a study while highlighting its importance at the foundations of many research efforts. Discover the key limitations of some target enrichment techniques and the new technologies that are improving this step, leading to a new suite of applications in oncology research, where damaged or degraded DNA samples are common.
Listen today for an overview of the target enrichment process, the most exciting applications of this technique future potential of this step.
Contents:
- Intro: 00:00-01:30
- Why conduct target enrichment? 00:40-02:45
- Established technologies for target enrichment: 02:45-04:10
- Challenges of working with these technologies: 04:20-06:40
- The impact of these challenges on sequencing results: 06:40-07:35
- New technologies to address these challenges: 07:35-09:25
- Primer extension in PCR and target enrichment: 09:25-11:40
- Exciting applications of primer extension target enrichment: 11:40-13:25
- Improving target enrichment in oncology and its impact on the field: 13:25-16:15
- If you could ask for one thing to enable primer extension target enrichment to make the greatest possible impact on the NGS and oncology communities, what would it be? 16:15-18:00
Hosted on Acast. See acast.com/privacy for more information.
57 에피소드
Manage episode 305554977 series 2902208
In this episode, supported by Roche, we explore a vital aspect of many next-generation sequencing studies: target enrichment. Here, regions of interest are selectively amplified before sequencing takes place. More specifically we examine some of the new technologies improving this key step and their impact on oncology research.
My guest for this episode is Brian Godwin, Director of Reagent and Assay Development at Roche sequencing. Brian reveals the myriad of ways that poor target enrichment can impact a study while highlighting its importance at the foundations of many research efforts. Discover the key limitations of some target enrichment techniques and the new technologies that are improving this step, leading to a new suite of applications in oncology research, where damaged or degraded DNA samples are common.
Listen today for an overview of the target enrichment process, the most exciting applications of this technique future potential of this step.
Contents:
- Intro: 00:00-01:30
- Why conduct target enrichment? 00:40-02:45
- Established technologies for target enrichment: 02:45-04:10
- Challenges of working with these technologies: 04:20-06:40
- The impact of these challenges on sequencing results: 06:40-07:35
- New technologies to address these challenges: 07:35-09:25
- Primer extension in PCR and target enrichment: 09:25-11:40
- Exciting applications of primer extension target enrichment: 11:40-13:25
- Improving target enrichment in oncology and its impact on the field: 13:25-16:15
- If you could ask for one thing to enable primer extension target enrichment to make the greatest possible impact on the NGS and oncology communities, what would it be? 16:15-18:00
Hosted on Acast. See acast.com/privacy for more information.
57 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.